Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: A long term follow-up study

Acta Myologica

Volumn 31, Issue OCTOBER, 2012, Pages 139-143

  Nigro, Gerardo ^a   Russo, Vincenzo ^a   Rago, Anna ^a   Papa, Andrea Antonio ^a   Palladino, Alberto ^a   Politano, Luisa ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Atrial fibrillation; Atrial preference pacing; Myotonic dystrophy

Indexed keywords

ADULT; ALGORITHM; ARTICLE; ATRIAL PREFERENCE PACING; ATRIOVENTRICULAR BLOCK; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LONG TERM CARE; MALE; MYOTONIC DYSTROPHY; RANDOMIZED CONTROLLED TRIAL; CLINICAL EFFECTIVENESS; FIRST DEGREE ATRIOVENTRICULAR BLOCK; HEART ATRIUM PACEMAKER; HEART RIGHT ATRIUM; IMPLANTED HEART PACEMAKER; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; SECOND DEGREE ATRIOVENTRICULAR BLOCK; SUPRAVENTRICULAR PREMATURE BEAT;

ADULT; ALGORITHMS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CROSS-OVER STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY; PATIENT SELECTION; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84869166458     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Emery AE. Heritability of common neuromuscular diseases. Neuromuscul Disord 2010;20:476.
2. Harper PS. Myotonic Dystrophy: some genetic problems. Birth Defects Orig Artic Ser 1974;10:120-5.
3. Harley HG, Brook JD, Rundle SA, et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992;355:545-6.
4. Phillips MF, Harper PS. Cardiac disease in myotonic dystrophy. Cardiovasc Res 1997;33:13-22. (Pubitemid 27019094)
5. Hawley RJ, Gottdiener JS, Gay JA, et al. Families with myotonic dystrophy with and without cardiac involvement.Arch Intern Med 1983;143:2134-6. (Pubitemid 14225184)
6. Nigro G, Comi LI, Politano L, et al. Cardiomyopathies associated with Muscular Dystrophies. In: Engel A, Franzini-Armstrong C. Myology. New York: Mac Graw-Hill 2004, pp. 1239-56 and references therein.
7. Nguyen HH, Wolfe JT III, Holmes DR Jr, et al. Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases. J Am Coll Cardiol 1988;11:662-71. (Pubitemid 18060228)
8. Dello Russo A, Mangiola F, Della Bella P, et al. Risk of arrhythmias in myotonic dystrophy: trial design of the RAMYD study. J Cardiovasc Med (Hagerstown) 2009;10:51-8.
9. Cudia P, Bernasconi P, Chiodelli R, et al. Risk of arrhythmia in type I myotonic dystrophy: the role of clinical and genetic variables. J Neurol Neurosurg Psychiatry 2009;80:790-3.
10. Magri D, Piccirillo G, Bucci E, et al. Increased temporal dispersion of myocardial repolarization in myotonic dystrophy type 1: beyond the cardiac conduction system. Int J Cardiol 2012;156:259-64.
11. Nigro G, Russo V, Rago A, et al. Heterogeneity of ventricular repolarization in newborns with severe aortic coarctation. Pediatr Cardiol 2012;33:302-6.
12. Russo V, Rago A, Pannone B, et al. Dispersion of repolarization and beta-thalassemia major: the prognostic role of QT and JT dispersion for identifying the high-risk patients for sudden death. Eur J Haematol 2011;86:324-31.
13. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American college of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106:2145-61. (Pubitemid 35192824)
14. Russo V, Rago A, D'Andrea A, et al. Early onset "electrical" heart failure in myotonic dystrophy type 1 patient: the role of ICD biventricular pacing. Anadolu Kardiyol Derg 2012;12:517-9
15. Lazarus A, Varin J, Babuty D, et al. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study. J Am Coll Cardiol 2002; 40:1645-52. (Pubitemid 35253643)
16. Russo V, Rago A, Politano L, et al. The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study. Europace 2012;14:486-9.
17. Lazarus A, Varin J, Ounnoughene Z, et al. Relationships among electrophysiological findings and clinical status, heart function and extent of DNA mutation in myotonic dystrophy. Circulation 1999;99:1041-6. (Pubitemid 29104494)
18. Vignaux O, Lazarus A, Varin J, et al. Right ventricular MR abnormalities in myotonic dystrophy and relationship with intracardiac electrophysiologic test findings: initial results. Radiology 2002;24:231-5. (Pubitemid 34685512)
19. Vinereanu D, Bajaj BP, Fenton-May J, et al. Subclinical cardiac involvement in myotonic dystrophy manifesting as decreased myocardial Doppler velocities. Neuromuscul Disord 2004;14:188-94. (Pubitemid 38229887)
20. Dello Russo A, Pelargonio G, Parisi Q, et al. Widespread electroanatomic alterations of right cardiac chambers in patients with myotonic dystrophy type1. J Cardiovasc Electrophysiol 2006;17:34-40.
21. Rotundo IL, Faraso S, De Leonibus E, et al. Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy. PLoS One 2011;6:e24729.
22. Vitiello C, Faraso S, Sorrentino NC, et al. Disease rescue and increased lifespan in a model of cardiomyopathy and muscular dystrophy by combined AAV treatments. PLoS One 2009;4:e5051.
23. Lancioni A, Rotundo IL, Kobayashi YM, et al. Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex. Hum Mol Genet 2011;20:4644-54.
24. Politano L, Nigro G. Treatment of dystrophinopathic cardiomyopathy: review of the literature and personal results. Acta Myol 2012;31:24-30.
25. D'Andrea A, Salerno G, Scarafile R, et al. Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy. Pacing Clin Electrophysiol 2009;32:1017-29.
26. Nigro G, Russo V, Vergara P, et al. Optimal site for atrial lead implantation in myotonic dystrophy patients: the role of Bachmann's Bundle stimulation. Pacing Clin Electrophysiol 2008;31:1463-6.
27. Nigro G, Russo V, Politano L et al. Right atrial appendage versus Bachmann's bundle stimulation: a two-year comparative study of electrical parameters in myotonic dystrophy type-1 patients. Pacing Clin Electrophysiol 2009;32:1191-6.
28. Nigro G, Russo V, Rago A, et al. The main determinant of hypotension in nitroglicerine tilt-induced vasovagal syncope. Pacing Clin Electrophysiol 2012;35:739-48.
29. Sopher SM, Camm AJ. Atrial pacing to prevent atrial fibrillation? J Intervent Card Electrophysiol 2000;4:149-53. (Pubitemid 30236068)
30. Mehra R, Hill MRS. Prevention of atrial fibrillation/flutter by pacing techniques. In: Saksena S, Luderlitz B, eds. Interventional Electrophysiology: A Textbook, 2nd ed. Armonk, NY: Futura Publishing 1996, pp. 521-40.
31. Nigro G, Russo V, Politano L, et al. Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study. Europace 2010;12:1219-23.
32. Carlson M, Ip J, Messenger J, et al. A new pacemaker algorithm for the treatment of atrial fibrillation. Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 2003;42:627-33. (Pubitemid 37000176)
33. Gold M, Adler S, Fauchier L, et al. Impact of atrial prevention pacing on atrial fibrillation burden: primary results of the Study of Atrial Fibrillation Reduction (SAFARI) trial. Heart Rhythm 2009;6:295-301.
34. Ogawa H, Ishikawa T, Matsushita K, et al. Effects of right Atrial Pacing Preference in prevention of paroxysmal atrial fibrillation Atrial Pacing Preference Study (APP Study). Circ J 2008;72:700-4. (Pubitemid 351716672)
35. Camm AJ, Sulke N, Edvardsson N, et al. Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation - the AFTherapy study. Europace 2007;9:1110-8. (Pubitemid 351773272)
36. Sulke N, Silberbauer J, Boodhoo L, et al. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study. Europace 2007;9:790-7. (Pubitemid 47371656)